Outcomes of “real world” treatment for metastatic renal cell carcinoma (mRCC).
Michael Roger Harrison
Honoraria - Novartis
Research Funding - Pfizer
Daniel J. George
Consultant or Advisory Role - Astellas Pharma; Bayer; Genentech; Novartis; Pfizer
Honoraria - Genentech; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Mark S. Walker
No relevant relationships to disclose
Lori L. Hudson
Research Funding - Pfizer
Connie Chen
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Beata Korytowsky
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Edward J. Stepanski
No relevant relationships to disclose
Amy P. Abernethy
Consultant or Advisory Role - Amgen; Helsinn Therapeutics; Novartis
Research Funding - Alexion Pharmaceuticals; Amgen; BioVex; Bristol-Myers Squibb; DARA BioSciences; Helsinn Therapeutics; Kanglaite Pharmaceutical ; Lilly; Mi-Co; Novartis; Pfizer